Ikarian Capital, LLC’s Cytokinetics Inc Position
Does Ikarian Capital, LLC own Cytokinetics Inc (CYTK)? Yes — 283.6K shares worth $19M (+1.52% of its 13F portfolio) as of Q1 2026, up from 172.7K shares the prior filed quarter.
Position Value
$19M
Q1 2026
Shares
283.6K
% of Portfolio
+1.52%
Quarters Held
15
currently held
Position History CYTK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 283.6K | $19M | +1.52% |
| Q4 2025 | 172.7K | $11M | +0.86% |
| Q3 2025 | 222.7K | $12M | +1.24% |
| Q2 2025 | 233.5K | $8M | +1.48% |
| Q1 2025 | 150.0K | $6M | +0.74% |
| Q4 2024 | 150.0K | $7M | +0.96% |
| Q3 2024 | 170.1K | $9M | +1.25% |
| Q2 2024 | 170.1K | $9M | +1.61% |
| Q1 2024 | 145.1K | $10M | +1.12% |
| Q4 2023 | 30.0K | $3M | +0.23% |
| Q1 2023 | 55.7K | $2M | +0.44% |
| Q2 2021 | 120.9K | $2M | +0.19% |
| Q1 2021 | 127.0K | $3M | +0.10% |
| Q4 2020 | 227.0K | $5M | +0.21% |
| Q3 2020 | 55.0K | $1M | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ikarian Capital, LLC’s full portfolio or all institutional holders of CYTK.